Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03740828 · ClinicalTrials.gov registry record
KIDScore D3 Clinical Study
A clinical trial of Infertility, sponsored by Vitrolife.
- Completed
- Registry status
- 81
- Enrollment target
- 6
- Study locations
NCT03740828: Completed study of Infertility, sponsored by Vitrolife.
NCT03740828 is a study of Infertility that has completed, run by Vitrolife. The registered enrollment target is 81 participants, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (99% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03740828, a study of Infertility, has completed, sponsored by Vitrolife.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
- 6
- Study locations
Study Summary
The aim of this study is to demonstrate that the KIDScore D3 may be used to identify those embryos on Day 3 that are most likely to form blastocysts.
Primary Outcome
The primary endpoint of this study was to assess the association between the adjunct prediction using KIDScore D3 of blastocyst outcome and the actual blastocyst outcome. The Odds Ratio (OR) for the adjunct prediction of blastulation is required to be statistically significantly greater than 1, for good/fair embryos. This will demonstrate that adjunctive use of KIDScore D3 leads to embryologist predictions for Day 5 blastulation that is informative for blastocysts outcome.
Conditions Studied
Interventions
- DEVICE KIDScore D3
Study Locations (6)
California
- Fertility Specialists Medical Group, Inc - San Diego
- Laurel Fertility Care - San Francisco
- Pacific Fertility - San Francisco
Florida
- South Florida Institute Fro Reproductive Medicine - Miami
Indiana
- Midwest Fertility Institute - Carmel
New York
- New York Fertility Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2016-09-20 |
| Est. Completion | 2017-10-12 |
What the finished NCT03740828 record still lists
NCT03740828 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which KIDScore D3 is the first listed.
NCT03740828 lists 6 locations in 4 states (California, Florida, Indiana).
Frequently Asked Questions
What is clinical trial NCT03740828 about?
NCT03740828 is a clinical study titled "KIDScore D3 Clinical Study". The aim of this study is to demonstrate that the KIDScore D3 may be used to identify those embryos on Day 3 that are most likely to form blastocysts.
What is the current status of trial NCT03740828?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2016-09-20. Estimated completion is 2017-10-12.
What conditions does trial NCT03740828 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT03740828?
The interventions under investigation include: KIDScore D3 (DEVICE).
Who is sponsoring clinical trial NCT03740828?
This trial is sponsored by Vitrolife, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03740828 being conducted?
This trial has 6 study locations across California, Florida, Indiana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03740828's enrollment target sits among peer trials
81 56th of 74 higher than 19 of 74 other Infertility trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Discarded Materials Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI